Trulieve Cannabis Corp. (TRLV) stock
TRLVNYSEMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3033% below fair value
$10.02−0.05 (-0.50%)
Close on Nov 18, 2026Market cap $1.93BP/E –Yield –
Trulieve Cannabis revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Trulieve Cannabis's revenue for the twelve months ending Jun 30, 2026 was $1.14B, down 3.9% year over year. For fiscal 2025 it was $1.18B, down 0.4% from the year before. The highest annual figure on record is $1.22B in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.18B | -0.4% |
| FY2024 | Dec 31, 2024 | $1.19B | +5.1% |
| FY2023 | Dec 31, 2023 | $1.13B | -7.3% |
| FY2022 | Dec 31, 2022 | $1.22B | +30.7% |
| FY2021 | Dec 31, 2021 | $931.93M | +78.7% |
| FY2020 | Dec 31, 2020 | $521.53M | +106.3% |
| FY2019 | Dec 31, 2019 | $252.82M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $270.95M | -10.3% |
| Q1 FY2026 | Mar 31, 2026 | $286.75M | -3.7% |
| Q4 FY2025 | Dec 31, 2025 | $293.15M | -2.7% |
| Q3 FY2025 | Sep 30, 2025 | $288.19M | +1.4% |
| Q2 FY2025 | Jun 30, 2025 | $302.09M | -0.4% |
| Q1 FY2025 | Mar 31, 2025 | $297.76M | +0.0% |
| Q4 FY2024 | Dec 31, 2024 | $301.15M | +4.9% |
| Q3 FY2024 | Sep 30, 2024 | $284.28M | +3.3% |
| Q2 FY2024 | Jun 30, 2024 | $303.44M | +7.7% |
| Q1 FY2024 | Mar 31, 2024 | $297.62M | +4.3% |
| Q4 FY2023 | Dec 31, 2023 | $286.97M | -3.9% |
| Q3 FY2023 | Sep 30, 2023 | $275.21M | -6.8% |
| Q2 FY2023 | Jun 30, 2023 | $281.80M | -10.2% |
| Q1 FY2023 | Mar 31, 2023 | $285.21M | -10.2% |
| Q4 FY2022 | Dec 31, 2022 | $298.48M | -0.1% |
| Q3 FY2022 | Sep 30, 2022 | $295.35M | +31.8% |
| Q2 FY2022 | Jun 30, 2022 | $313.84M | +45.9% |
| Q1 FY2022 | Mar 31, 2022 | $317.75M | +63.9% |
| Q4 FY2021 | Dec 31, 2021 | $298.90M | +77.5% |
| Q3 FY2021 | Sep 30, 2021 | $224.09M | +64.4% |
| Q2 FY2021 | Jun 30, 2021 | $215.12M | +78.1% |
| Q1 FY2021 | Mar 31, 2021 | $193.82M | +101.8% |
| Q4 FY2020 | Dec 31, 2020 | $168.44M | – |
| Q3 FY2020 | Sep 30, 2020 | $136.27M | – |
| Q2 FY2020 | Jun 30, 2020 | $120.77M | – |
| Q1 FY2020 | Mar 31, 2020 | $96.06M | – |
See a number that looks wrong?